Literature DB >> 7028939

Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses.

J M Gordon, C B Walker, J C Murphy, J M Goodson, S S Socransky.   

Abstract

The concentration of tetracycline in gingival crevice fluid and blood was determined using a sensitive bioassay after oral administration of repeated doses of tetracycline. Crevicular fluid was sampled by an intracrevicular technique from four gingival sites in each individual and blood was obtained by finger puncture. Four volunteers received doses of 250 mg of tetracycline-HCl either every 6 hours or every 12 hours and were sampled at hours 0 to 15, 21 to 36, 48 to 60 and 96 to 102. Volunteers given 250 mg every 6 hours had average crevicular fluid concentrations between 4 to 8 micrograms/ml and blood concentrations between 2 to 2.5 micrograms/ml after 48 hours. The levels in crevicular fluid and blood of volunteers who received 250 mg every 12 hours were 2 to 4 micrograms/ml and 0.3 to 1.4 micrograms/ml respectively after 48 hours. The results demonstrated that after repeated doses of tetracycline the crevicular fluid levels were typically 2 to 4 times the blood levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028939     DOI: 10.1902/jop.1981.52.10.609

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  7 in total

1.  Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential.

Authors:  K Suomalainen; T Sorsa; L M Golub; N Ramamurthy; H M Lee; V J Uitto; H Saari; Y T Konttinen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  The use of povidone-iodine and hydrogen peroxide mixture as an adjunct to non-surgical treatment of slight to moderate chronic periodontitis.

Authors:  Mohammed Y Al-Saeed; Nadir Babay
Journal:  Saudi Dent J       Date:  2009-10-29

3.  Antibiotic resistance in an in vitro subgingival biofilm model.

Authors:  M J Sedlacek; C Walker
Journal:  Oral Microbiol Immunol       Date:  2007-10

4.  Azithromycin concentrations in blood and gingival crevicular fluid after systemic administration.

Authors:  Pin-Chuang Lai; Weiting Ho; Nidhi Jain; John D Walters
Journal:  J Periodontol       Date:  2011-03-21       Impact factor: 6.993

5.  Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases.

Authors:  D S Jones; A D Woolfson; J Djokic; W A Coulter
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

6.  Subinhibitory concentrations of tetracycline alter fibrinogen binding by Bacteroides intermedius.

Authors:  M S Lantz; T Ray; S Krishnasami; D E Pearson
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

Review 7.  Commercial Local Pharmacotherapeutics and Adjunctive Agents for Nonsurgical Treatment of Periodontitis: A Contemporary Review of Clinical Efficacies and Challenges.

Authors:  Oi Leng Tan; Syarida Hasnur Safii; Masfueh Razali
Journal:  Antibiotics (Basel)       Date:  2019-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.